We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$58B
AUM Growth
+$600M
Cap. Flow
+$168M
Cap. Flow %
0.29%
Top 10 Hldgs %
29.71%
Holding
2,095
New
25
Increased
699
Reduced
938
Closed
74

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$162M
2
AAPL icon
Apple
AAPL
+$143M
3
MRSH
Marsh
MRSH
+$133M
4
MSFT icon
Microsoft
MSFT
+$115M
5
WMB icon
Williams Companies
WMB
+$75.4M

Top Sells

Rank Stock Value
1
BLK icon
Blackrock
BLK
+$118M
2
LRCX icon
Lam Research
LRCX
+$106M
3
AVGO icon
Broadcom
AVGO
+$96.6M
4
ANET icon
Arista Networks
ANET
+$92.5M
5
JNJ icon
Johnson & Johnson
JNJ
+$79.9M

Sector Composition

Rank Sector Weight
1 Technology 31.36%
2 Financials 13.67%
3 Consumer Discretionary 11.77%
4 Healthcare 10.58%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSEX icon
1451
Middlesex Water
MSEX
$1.07B
$1.08M ﹤0.01%
20,614
+443
+2% +$27.8K
SCSC icon
1452
Scansource
SCSC
$1.11B
$1.08M ﹤0.01%
22,823
VICR icon
1453
Vicor
VICR
$9.96B
$1.08M ﹤0.01%
22,387
-852
-4% -$42.6K
PMT
1454
PennyMac Mortgage Investment
PMT
$817M
$1.07M ﹤0.01%
85,027
MGRC icon
1455
McGrath RentCorp
MGRC
$2.93B
$1.07M ﹤0.01%
9,592
-769
-7% -$88.2K
PSEC icon
1456
Prospect Capital
PSEC
$1.14B
$1.07M ﹤0.01%
248,301
-18,834
-7% -$90.3K
AORT icon
1457
Artivion
AORT
$1.28B
$1.05M ﹤0.01%
36,890
-14,756
-29% -$409K
MD icon
1458
Pediatrix Medical
MD
$2.13B
$1.04M ﹤0.01%
79,653
TAC icon
1459
TransAlta
TAC
$3.89B
$1.04M ﹤0.01%
73,942
+5,168
+8% +$59K
OR icon
1460
OR Royalties Inc
OR
$6.27B
$1.04M ﹤0.01%
58,123
-973
-2% -$18.9K
MNRO icon
1461
Monro
MNRO
$370M
$1.03M ﹤0.01%
41,720
-436
-1% -$11.9K
HURN icon
1462
Huron Consulting
HURN
$2.45B
$1.03M ﹤0.01%
8,267
EFC
1463
Ellington Financial
EFC
$1.68B
$1.02M ﹤0.01%
84,360
-39,883
-32% -$493K
EYE icon
1464
National Vision
EYE
$1.8B
$997K ﹤0.01%
95,724
-6,667
-7% -$72.9K
VCYT icon
1465
Veracyte
VCYT
$3.73B
$997K ﹤0.01%
25,217
+1,395
+6% +$52.8K
HSTM icon
1466
HealthStream
HSTM
$864M
$985K ﹤0.01%
31,064
+1,843
+6% +$56.9K
HL icon
1467
Hecla Mining
HL
$11.7B
$984K ﹤0.01%
201,097
-4,185
-2% -$25K
OSG
1468
Octave Specialty Group
OSG
$208M
$981K ﹤0.01%
77,655
AMSF icon
1469
AMERISAFE
AMSF
$528M
$981K ﹤0.01%
19,027
-1,348
-7% -$73K
CRNX icon
1470
Crinetics Pharmaceuticals
CRNX
$8.94B
$981K ﹤0.01%
19,219
+1,880
+11% +$105K
SSTK icon
1471
Shutterstock
SSTK
$218M
$979K ﹤0.01%
32,254
+1,745
+6% +$54.8K
GH icon
1472
Guardant Health
GH
$22.8B
$978K ﹤0.01%
32,043
UHT
1473
Universal Health Realty Income Trust
UHT
$576M
$977K ﹤0.01%
26,289
+1,378
+6% +$56.1K
PRAA icon
1474
PRA Group
PRAA
$742M
$973K ﹤0.01%
46,671
MCRI icon
1475
Monarch Casino & Resort
MCRI
$2.18B
$972K ﹤0.01%
12,337
-1,050
-8% -$84.7K

Similar funds

Canada Life's Q4 2024 Portfolio in Review

As of Q4 2024, Canada Life held 2,095 positions worth $58B, up 1% from $57.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.7%. Canada Life opened 25 new positions and exited 74, leaving the 2,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Canada Life's largest Q4 2024 buy was iShares MSCI ACWI ETF: 233,743 shares worth $27.4M.
  • Canada Life added most to Meta Platforms (Facebook) in Q4 2024, an estimated $162M increase.
  • Canada Life's biggest Q4 2024 reduction was Broadcom, cutting an estimated $96.6M.
  • Canada Life fully exited Blackrock in Q4 2024, selling an estimated $118M.
  • Canada Life's ten largest holdings make up 30% of its $58B portfolio in Q4 2024.
  • Canada Life opened 25 new positions and closed 74 in Q4 2024.
  • Canada Life's portfolio value rose 1% quarter-over-quarter to $58B.

Based on Canada Life's 13F filing for Q4 2024, filed 13 Feb 2025.